Benzinga | Nov 9, 2021 06:08PM EST

Augmedix Q3 Net Loss $2.859M, Adj. EBITDA Loss $3.886M, Sales $5.63M Beat $5.61M Estimate

Augmedix (NASDAQ:AUGX) reported quarterly sales of $5.63 million which beat the analyst consensus estimate of $5.61 million by 0.27 percent. This is a 32.51 percent increase over sales of $4.25 million the same period last year.